Skip to content

KYTHERA BIOPHARMACEUTICALS INC: filings

Every KYTHERA BIOPHARMACEUTICALS INC annual and quarterly report in the SEC record with the published financial measures it tagged, 15 filings, each linked to its SEC index.

Filing record ends 2015-08-06

The latest filing in this captured record is a 10-Q filed 2015-08-06. No later filing is in the SEC companyfacts record captured on 2026-09-22. KYTHERA BIOPHARMACEUTICALS INC may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2015-08-06fiscal Q2 201530730001558370-15-001486
10-Q2015-05-07fiscal Q1 201529580001104659-15-035576
10-K2015-03-02fiscal FY 2014331000001047469-15-001515
10-Q2014-11-10fiscal Q3 201428710001104659-14-078700
10-Q2014-08-07fiscal Q2 201428710001104659-14-058293
10-Q2014-05-08fiscal Q1 201428570001104659-14-036494
10-K2014-03-17fiscal FY 2013331060001047469-14-002466
10-Q2013-11-14fiscal Q3 201328700001104659-13-084832
10-Q/A2013-09-27fiscal Q2 201332860001104659-13-072568
10-Q/A2013-09-27fiscal Q1 201328550001104659-13-072567
10-K/A2013-09-27fiscal FY 2012291040001047469-13-009348
10-Q2013-08-06fiscal Q2 201328700001104659-13-060439
10-Q2013-05-13fiscal Q1 201328550001104659-13-040811
10-K2013-03-26fiscal FY 201227960001047469-13-003382
10-Q/A2012-12-03fiscal Q3 201225650001104659-12-081494

Inspect the source

Entity
KYTHERA BIOPHARMACEUTICALS INC / CIK 0001436304
Captured
SEC response SHA-256
678ac0d76e4b9e2b736149ae4b0f3ca6dec21f26ed696e9de5f459ba4c1b46eb

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001436304.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))